# ONCO catalysts: Onconetix, Inc. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/onco/catalysts

> Onconetix, Inc. (ONCO) has no upcoming catalysts in this calendar. The latest recorded is the Adcirca® (tadalafil) FDA approval, September 30, 2024.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only, exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA catalysts for ONCO?

Onconetix, Inc. (ONCO) has no upcoming catalysts in this calendar. The latest recorded is the Adcirca® (tadalafil) FDA approval, September 30, 2024. SEC Form 10-Q: "During the nine months ended September 30, 2024, the Company became aware of a new competitor that received approval by the FDA for a combined finasteride-tadalafil capsule, which is a direct competitor product to ENTADFI." [Calendar and source filings](https://sec-api.dev/companies/onco/catalysts)

Source: SEC Form 10-Q, accession 0001213900-25-110142, https://www.sec.gov/Archives/edgar/data/1782107/000121390025110142/ea0264964-10q_onconetix.htm (retrieved 2026-11-12). Last confirmed 2025-11-13. Cite: https://sec-api.dev/companies/onco/catalysts#answer

## Company

| Field | Value |
| --- | --- |
| Name | Onconetix, Inc. |
| Ticker | ONCO (Nasdaq) |
| SEC CIK | 1782107 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/onco |

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Sep 2022 | [Adcirca® (tadalafil) FDA approval](https://sec-api.dev/pdufa/tadalafil) | ONCO |  | completed, approved | "It received FDA approval in September 2022." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1782107/000121390025029639/ea023747101ex99-1_oncon.htm)) |
| March 31, 2024 | [Adcirca® (tadalafil) FDA approval](https://sec-api.dev/pdufa/tadalafil) | ONCO |  | completed, approved | "During the three months ended March 31, 2024, the Company became aware of a new competitor that received approval by the FDA for a combined finasteride-tadalafil capsule, which is a direct competitor product to ENTADFI." ([SEC Form 10-Q](https://www.sec.gov/Archives/edgar/data/1782107/000121390025053914/ea0245287-10q_onconetix.htm)) |
| September 30, 2024 | [Adcirca® (tadalafil) FDA approval](https://sec-api.dev/pdufa/tadalafil) | ONCO |  | completed, approved | "During the nine months ended September 30, 2024, the Company became aware of a new competitor that received approval by the FDA for a combined finasteride-tadalafil capsule, which is a direct competitor product to ENTADFI." ([SEC Form 10-Q](https://www.sec.gov/Archives/edgar/data/1782107/000121390025110142/ea0264964-10q_onconetix.htm)) |

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/onco/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "ONCO catalysts: Onconetix, Inc. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/onco/catalysts

```bibtex
@misc{secapidev_companies_onco_catalysts_20261116,
  title        = {ONCO catalysts: Onconetix, Inc. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/onco/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_onco_catalysts_20261116","title":"ONCO catalysts: Onconetix, Inc. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/onco/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
